Glaxo SmithKline PLC.

PositionRichard Kent appointed CEO of Ardent Pharmaceuticals Inc. - Brief Article

DURHAM -- Richard Kent, former chief medical officer of Glaxo SmithKline PLC, has become CEO of Ardent Pharmaceuticals Inc. Ardent, which had changed its name from Delta Pharmaceuticals Inc. a week earlier, is developing drugs to...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT